Spectroscopic analysis of metabolic profile in patients with relapsed multiple sclerosis

Introduction. Managing patients with relapsing-remitting multiple sclerosis (RMS) remains a pressing issue. Objective. To detect the reversible metabolic changes of the brain matter in patients with clinically exacerbated RMS and to follow them up after intravenous glucocorticoid (IVGC) treatment...

Full description

Bibliographic Details
Main Authors:	Galina G. Shkilnyuk, Andrey A. Bogdan, Elena V. Kryukova, Andrey M. Petrov, Tatyana N. Trofimova, Igor D. Stolyarov
Format:	Article
Language:	English
Published:	Research Center of Neurology 2022-12-01
Series:	Анналы клинической и экспериментальной неврологии
Subjects:	multiple sclerosis relapse multivoxel 1nmr spectroscopy glucocorticoid treatment predictors
Online Access:	https://annaly-nevrologii.com/journal/pathID/article/viewFile/841/pdf

Similar Items

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
by: Cristina Ramo-Tello, et al.
Published: (2021-12-01)

Definition and treatment of the multiple sclerosis relapse (ORP-10)
by: Maryam Poursadeghfard
Published: (2023-11-01)

Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning
by: Ziya EKŞİ, et al.

Cognitive Relapse in Multiple Sclerosis: New Findings and Directions for Future Research
by: Zachary L. Weinstock, et al.
Published: (2022-08-01)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study
by: Giuseppina Miele, et al.
Published: (2023-01-01)

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment
by: Serhan Sevim
Published: (2016-09-01)

CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS
by: Rizaldy Taslim Pinzon, et al.
Published: (2017-11-01)

Vitamin D intoxication in a patient with relapsing-remitting multiple sclerosis – case report
by: Ioana Cociasu, et al.
Published: (2015-09-01)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
by: Ali Khatibi, et al.
Published: (2020-03-01)

Predictors of severity and outcome of multiple sclerosis relapses
by: Hassan Saad Hosny, et al.
Published: (2023-02-01)

Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study
by: Martha Rocio Hernández-Preciado, et al.
Published: (2022-06-01)

The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
by: Mehrdokht Mazdeh, et al.
Published: (2018-11-01)

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis
by: David Haschka, et al.
Published: (2020-04-01)

Associations among stressors across the lifespan, disability, and relapses in adults with multiple sclerosis
by: Carri S. Polick, et al.
Published: (2023-07-01)

Osteopontin Is Associated with Multiple Sclerosis Relapses
by: Mario Stampanoni Bassi, et al.
Published: (2023-01-01)

Outcomes of AstraZeneca vaccine for relapse and Covid-19 infection in people with multiple sclerosis
by: Nazanin Razazian, et al.
Published: (2022-09-01)

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
by: Katarzyna Kapica-Topczewska, et al.
Published: (2021-02-01)

Identification of Inappropriate Diets in People with Multiple Sclerosis with Relapses in the Past Year: A Qualitative Study
by: Mozaffar Hosseininezhad, et al.
Published: (2021-01-01)

A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
by: Mehrdokht Mazdeh, et al.
Published: (2019-04-01)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01)

Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis
by: Sherein G. Elgendy, et al.
Published: (2021-10-01)

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
by: Tatiana Koudriavtseva, et al.
Published: (2020-10-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Outcome of MS relapses in the era of disease-modifying therapy
by: Muriel Stoppe, et al.
Published: (2017-08-01)

Multimodal evoked potential in monitoring activity relapsing and remitting multiple sclerosis
by: Poverennova I.E., et al.
Published: (2018-03-01)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
by: Oliver Findling, et al.
Published: (2018-08-01)

Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study
by: Xingwei Fang, et al.
Published: (2023-06-01)

Comparing the Efficacy of Monthly Cyclophosphamide as Monotherapy versus Daily Fingolimod in Relapsing Remitting and Secondary Progressive Multiple Sclerosis
by: Vahid Shaygannezhad, et al.
Published: (2017-08-01)

Physical activity is related to disease severity and fatigue, but not to relapse rate in persons with relapsing remitting multiple sclerosis – a self-reported questionnaire based study
by: Marit L. Schlagheck, et al.
Published: (2023-07-01)

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
by: Antonia Pignolo, et al.
Published: (2021-12-01)

Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
by: Tatiana Koudriavtseva, et al.
Published: (2023-07-01)

Postural Control in Relapsing-Remitting Multiple Sclerosis
by: Flavia Salvaterra Cusin, et al.
Published: (2022-10-01)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

Investigation of oxidative stress in relapse and remission periods of patients with relapsing-Remitting multiple sclerosis
by: Samet Oncel, et al.
Published: (2021-01-01)

The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
by: Mohammad Balabandian, et al.
Published: (2024-01-01)

Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis
by: Yeseul Kim, et al.
Published: (2018-10-01)

Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-03-01)

Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-03-01)

The pure effects of occurrence relapse on fatigue and quality of life in patients with multiple sclerosis: A post hoc analysis with high statistical control
by: GHASEM salehpoor, et al.
Published: (2018-11-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
by: Halil Önder
Published: (2019-06-01)